{"id":342065,"date":"2026-11-06T14:20:52","date_gmt":"2026-11-06T08:50:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/supriya-lifescience-q2-results-fy27-pat-29-crore\/"},"modified":"2026-11-06T14:20:52","modified_gmt":"2026-11-06T08:50:52","slug":"supriya-lifescience-q2-results-fy27-pat-29-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/supriya-lifescience-q2-results-fy27-pat-29-crore\/","title":{"rendered":"Supriya Lifescience Q2 Results FY27: PAT Falls 42% to Rs 29.25 Cr, Revenue Up 3.24% to Rs 206.30 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Supriya Lifescience Q2 Results FY27 were declared on 6 November 2026 on a Standalone basis. Revenue rose 3.24% YoY to Rs 206.30 Cr from Rs 199.83 Cr, while net profit fell 42% to Rs 29.25 Cr from Rs 50.43 Cr. Operating Profit declined 37.51% to Rs 45.40 Cr. These quarterly results show YoY growth in sales but lower profit for July to September 2026.<\/p>\n<\/div>\n

Supriya Lifescience Ltd<\/a> (SUPRIYA) Q2 Results FY27 announced on 6 November 2026, covering the company’s financial performance for the July to September quarter. Supriya Lifescience Q2 Results FY27 show Standalone revenue of Rs 206.30 Cr and PAT of Rs 29.25 Cr. The results date and the standalone results basis frame every comparison below, since each figure is set against the same quarter a year earlier.<\/p>\n

This Supriya Lifescience Q2 Results walkthrough turns the results analysis into five parts: financial highlights, business drivers, the FY27 outlook, risks and common questions. The Financial Highlights table that follows sets the quarter beside the year-earlier period, with the YoY change for each line. Univest follows these filings for NSE and BSE listed companies.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n